Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib.
- DOI
- 10.1016/j.lungcan.2025.108808
- Published
- 2025-11-01
- Container
- Lung Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2025.108808,
title = {Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib.},
author = {Chen ACC and Mok FST and Wong WKY and Lam BHW and Johnson D and Lee MMP and Chan LL and Mo F and Mok KKS and Chen OH and Lee KWC and Loong HHF and Lam KC and Yan K and Mok TSK and Li MSC.},
year = {2025},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2025.108808},
url = {https://doi.org/10.1016/j.lungcan.2025.108808}
}RIS
TY - JOUR TI - Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib. AU - Chen ACC AU - Mok FST AU - Wong WKY AU - Lam BHW AU - Johnson D AU - Lee MMP AU - Chan LL AU - Mo F AU - Mok KKS AU - Chen OH AU - Lee KWC AU - Loong HHF AU - Lam KC AU - Yan K AU - Mok TSK AU - Li MSC. PY - 2025 JO - Lung Cancer DO - 10.1016/j.lungcan.2025.108808 UR - https://doi.org/10.1016/j.lungcan.2025.108808 ER -
APA
ACC, C., FST, M., WKY, W., BHW, L., D, J., MMP, L., LL, C., F, M., KKS, M., OH, C., KWC, L., HHF, L., KC, L., K, Y., TSK, M., & MSC., L. (2025). Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib.. Lung Cancer. https://doi.org/10.1016/j.lungcan.2025.108808
Source records
- europe-pmc · retrieved 2026-09-26T13:13:32.550Z